GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Entero Healthcare Solutions Ltd (BOM:544122) » Definitions » EBIT

Entero Healthcare Solutions (BOM:544122) EBIT : ₹1,333 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Entero Healthcare Solutions EBIT?

Entero Healthcare Solutions's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2024 was ₹832 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹1,333 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Entero Healthcare Solutions's annualized ROC % for the quarter that ended in Sep. 2024 was 5.90%. Entero Healthcare Solutions's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 16.41%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Entero Healthcare Solutions's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 2.78%.

Entero Healthcare Solutions EBIT Historical Data

The historical data trend for Entero Healthcare Solutions's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entero Healthcare Solutions EBIT Chart

Entero Healthcare Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24
EBIT
55.42 62.84 407.12 960.37

Entero Healthcare Solutions Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
EBIT Get a 7-Day Free Trial 134.16 272.96 459.63 500.74 832.37

Competitive Comparison of Entero Healthcare Solutions's EBIT

For the Medical Distribution subindustry, Entero Healthcare Solutions's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entero Healthcare Solutions's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Entero Healthcare Solutions's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Entero Healthcare Solutions's EV-to-EBIT falls into.


;
;

Entero Healthcare Solutions EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹1,333 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entero Healthcare Solutions  (BOM:544122) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Entero Healthcare Solutions's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=1170.44 * ( 1 - 24.99% )/( (12163.6 + 17580.4)/ 2 )
=877.947044/14872
=5.90 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=23449.75 - 3401.49 - ( 7884.66 - max(0, 6019.44 - 20109.75+7884.66))
=12163.6

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=26529 - 3919.35 - ( 5029.25 - max(0, 8489.63 - 20349.21+5029.25))
=17580.4

Note: The Operating Income data used here is two times the semi-annual (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Entero Healthcare Solutions's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1664.74/( ( (930.85 + max(8288.57, 0)) + (1343.07 + max(9724.93, 0)) )/ 2 )
=1664.74/( ( 9219.42 + 11068 )/ 2 )
=1664.74/10143.71
=16.41 %

where Working Capital is:

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6154.04 + 4211.55 + 1507.78) - (3401.49 + 0 + 183.31)
=8288.57

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8792.4 + 5987.01 + 525.85) - (3919.35 + 0 + 1660.98)
=9724.93

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Entero Healthcare Solutions's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=1333.11/48021.727
=2.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entero Healthcare Solutions EBIT Related Terms

Thank you for viewing the detailed overview of Entero Healthcare Solutions's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Entero Healthcare Solutions Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Entero Healthcare Solutions Ltd (BOM:544122) » Definitions » EBIT
Comparable Companies
NSE:REMUS NSE:DENTALKART BOM:544353 BOM:544143 BOM:536565 BOM:530697 BOM:543500 BOM:531240 BOM:523896 MCK COR CAH ASX:SIG HSIC SHSE:601607 HKSE:01099 MIL:AMP SHSE:600332 XSWX:GALE NZSE:EBO
Traded in Other Exchanges
ENTERO:India
Address
Bandra Kurla Complex, Trade Centre, Unit No. 605 & 606, 6th Floor, Bandra East, Mumbai, MH, IND, 400051
Website
https://www.enterohealthcare.com
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.

Entero Healthcare Solutions Headlines

No Headlines